Education
About Us
Working with TipRanks
Follow Us
Arno Therapeutics Inc (ARNI)
OTHER OTC:ARNI
Total Valuation
Arno Therapeutics has a market cap or net worth of $49.00. The enterprise value is ―.
Market Cap$49.00
Enterprise Value―
Share Statistics
Arno Therapeutics has 49,350,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding49,350,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Arno Therapeutics’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)0.00
Return on Assets (ROA)0.00
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00
Revenue Per Employee0.00
Profits Per Employee0.00
Employee Count4
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Arno Therapeutics is ―. Arno Therapeutics’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio―
Income Statement
In the last 12 months, Arno Therapeutics had revenue of 0.00 and earned 0.00 in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income0.00
Pretax Income0.00
Net Income0.00
EBITDA0.00
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -7.62M and capital expenditures 0.00, giving a free cash flow of -7.62M billion.
Operating Cash Flow-7.62M
Free Cash Flow-7.62M
Free Cash Flow per Share-0.15
Dividends & Yields
Arno Therapeutics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-40.63
52-Week Price Change0.00%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)615.78K
Important Dates
Arno Therapeutics upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Arno Therapeutics as a current ratio of 0.00, with Debt / Equity ratio of 0.00%
Current Ratio0.00
Quick Ratio0.00
Debt to Market Cap0.00
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Arno Therapeutics has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Arno Therapeutics EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 0.00.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
Arno Therapeutics has $2.12M in cash and marketable securities with $5.09K in debt, giving a net cash position of $2.12M billion.
Cash & Marketable Securities$2.12M
Total Debt$5.09K
Net Cash$2.12M
Net Cash Per Share$0.04
Tangible Book Value Per Share$0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Arno Therapeutics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―